Navigation Links
Richard Gephardt Joins Leading Innovators in Washington State to Call for Greater Focus on Policies to Boost Economy and Maintain U.S. Competitiveness in Medical Science and Innovation
Date:9/21/2009

SEATTLE, Sept. 21 /PRNewswire/ -- Several of the Pacific Northwest's leaders in biotechnology, health and medicine gathered at the University of Washington Medicine's South Lake Union Campus today to discuss the importance of medical innovation in the region, and to the United States.

The Council for American Medical Innovation, a national coalition of leaders in research, medicine, public health, patient advocacy, academia, business and labor is calling on Congress to adopt a national policy agenda aimed at preserving U.S. leadership in medical innovation. The Council hosted the event. Richard Gephardt, former Democratic Leader of the U.S. House of Representatives and chair of the Council for American Medical Innovation, moderated the forum, highlighting the contributions innovators in the state of Washington have made to public health and economic security. Panelists suggested that new discoveries in the life sciences and medicine are critical to region's economic recovery.

"Medical innovation has an enormous impact on the health and economy of the United States, and is a growing part of the economy in the state of Washington," Gephardt said. "When we find ways to support medical innovation, we create jobs, drive investment and improve our health. While America still leads the world in science and technology, other countries are gaining on us at amazing speeds. We need to act now by laying a strong foundation with intelligent policies that will preserve our leadership in medical innovation and allow science and medical discovery to flourish today, tomorrow, and into the future."

Biotechnology, including biopharmaceutical companies, directly employs nearly 20,000 people in Washington, representing a payroll of more than $1.6 billion. The Pacific Northwest has unique advantages in medicine, the life sciences and other innovative fields that can be har
'/>"/>

SOURCE The Council for American Medical Innovation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
2. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
6. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
7. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
8. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
9. Cytochroma Appoints R. Richard Wieland II As CFO
10. Abt Associates Names Richard Small Vice President and Chief Financial Officer
11. Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... PRC ... to develop new business relationships with local sponsors in southern California. The Clinical Trial ... their drug development processes and regulatory pathways., , Stem ...
(Date:8/25/2015)... Wis. (PRWEB) , ... August 25, 2015 , ... ... fermentor at its research facility in Knapp, Wis. The company has added a ... C15 Fermentor allows detailed data collection during bacterial or fungal fermentation process development. ...
(Date:8/25/2015)... 25, 2015  InformedDNA, a leading provider of ... been awarded Certification in Utilization Management by the ... NCQA is a private, non-profit organization dedicated ... wide range of healthcare organizations. It also recognizes ... "Our achievement of the NCQA Utilization ...
(Date:8/25/2015)... 25, 2015 MitoQ Ltd, the company ... latest addition to the brand,s growing portfolio of ... and highly targeted variation of MitoQ,s original supplement ... and insulin levels, weight management and key organ ... MitoQ, was developed at Otago University, Dunedin. It ...
Breaking Biology Technology:PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New centrifuge and fermentor expand product development capacity at Vets Plus 2InformedDNA Achieves NCQA Utilization Management Certification 2MitoQ Launches Revolutionary NZ-Developed Supplement to Support Blood Sugar Balance 2MitoQ Launches Revolutionary NZ-Developed Supplement to Support Blood Sugar Balance 3MitoQ Launches Revolutionary NZ-Developed Supplement to Support Blood Sugar Balance 4
... CINCINNATI, Sept. 22 Kendle (Nasdaq: KNDL ... Chairman and Chief Executive Officer Candace Kendle, PharmD, ... Conference. The,conference will be held at the Grand ... York City, Sept. 22-25, 2008. Kendle,s presentation is,scheduled ...
... at Upcoming Conferences, CALGARY, Sept. 22 /PRNewswire-FirstCall/ ... announced the participation of five of its,collaborators and ... 15, 2008 covering clinical trial results and preclinical,research ... Oncolytics as we begin to share additional,results of ...
... to Novel Beta Blocker ... ... unique beta-blocker and mild vasodilator, significantly,reduces hospitalization and death among heart ... DNA study presented,today as a poster at the annual meeting of ...
Cached Biology Technology:Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 2Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial 3Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes 2Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes 3
(Date:8/5/2015)... , August 5, 2015 ... & Access Management Market by Software, Services, Vertical (BFSI, Airport, ... & Geography - Global Forecast to 2020", published by ... Management Market globally into various segments. The global PIAM ... 2014 to $546.2 Million by 2019, at a CAGR ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... The Federation of American Societies for Experimental Biology (FASEB) ... the travel award recipients for the 2011 Annual Biomedical ... Louis, MO from November 9-12, 2011. These awards ... students, postdoctorates and scientists into the mainstream of the ...
... When a thief breaks into a bank vault, sensors ... own early-warning system for intruders, and scientists at the European ... a particular protein sounds that alarm when it detects invading ... a key development in our understanding of the innate immune ...
... Americans, African Americans are four to five times more likely ... with kidney failure have an increased risk of developing kidney ... this skewed risk between races. Previous studies identified variants in ... APOL1 gene creates a protein that is a component of ...
Cached Biology News:MARC Travel awards announced for the ABRCMS meeting 2MARC Travel awards announced for the ABRCMS meeting 3MARC Travel awards announced for the ABRCMS meeting 4MARC Travel awards announced for the ABRCMS meeting 5Intruder detected: Raise the alarm! 2Better ways to predict kidney disease risk for African Americans 2Better ways to predict kidney disease risk for African Americans 3
... Mo Bio luciferase assay. Mo Bio Laboratories offers ... allow you to certify your products ATP-Free with ... to deliver them to your customers in a ... is 3.5 x 10-12 /l, which will allow ...
Choriongonadotropin (human, hCG)...
... in Early Drug Development with Imaging Mass ... drug compound localization data in early drug ... mass spectrometry service maps unlabeled ... so you can localize drugs and metabolites ...
... micro-fractionation, spotting and preparation for MS ... eluent can be accurately and continuously ... amounts. This allows for automatic preparation ... When used in conjunction with Shimadzus ...
Biology Products: